{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:54:58Z","timestamp":1772546098707,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41401-024-01451-0","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T08:34:34Z","timestamp":1736843674000},"page":"1419-1432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genome-wide CRISPR-Cas9 screening identifies ITGA8 responsible for abivertinib sensitivity in lung adenocarcinoma"],"prefix":"10.1038","volume":"46","author":[{"given":"Xuan-guang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-sheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-he","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-xuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-hao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"1451_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1451_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1378\/chest.128.1.452","volume":"128","author":"P Yang","year":"2005","unstructured":"Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, et al. Clinical features of 5628 primary lung cancer patients experience at Mayo Clinic from 1997 to 2003. Chest. 2005;128:452\u201362.","journal-title":"Chest"},{"key":"1451_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354.","journal-title":"Nature"},{"key":"1451_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ctrc.2015.03.005","volume":"4","author":"A Saber","year":"2015","unstructured":"Saber A, van der Wekken A, Hiltermann TJN, Kok K, van den Berg A, Groen HJM. Genomic aberrations guiding treatment of non-small cell lung cancer patients. Cancer Treat Commun. 2015;4:23\u201333.","journal-title":"Cancer Treat Commun"},{"key":"1451_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/JTO.0000000000000033","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014;9:154\u201362.","journal-title":"J Thorac Oncol"},{"key":"1451_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrc2088","volume":"7","author":"SV Sharma","year":"2007","unstructured":"Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer. 2007;7:169\u201381.","journal-title":"Nat Rev Cancer"},{"key":"1451_CR7","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1158\/1535-7163.MCT-19-0181","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Wang T, Lv D, Li L, Yue J, Chen HZ, et al. Acquired resistance to EGFR TKIs mediated by TGFbeta1\/Integrin beta3 signaling in EGFR-mutant lung cancer. Mol Cancer Ther. 2019;18:2357\u201367.","journal-title":"Mol Cancer Ther"},{"key":"1451_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0777-1","volume":"17","author":"SG Wu","year":"2018","unstructured":"Wu SG, Shih JY. Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer. Mol Cancer. 2018;17:38.","journal-title":"Mol Cancer"},{"key":"1451_CR9","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","volume":"19","author":"HA Yu","year":"2013","unstructured":"Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, et al. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res. 2013;19:2240\u20137.","journal-title":"Clin Cancer Res"},{"key":"1451_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrc.2017.84","volume":"17","author":"J Rotow","year":"2017","unstructured":"Rotow J, Bivona TG. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017;17:637\u201358.","journal-title":"Nat Rev Cancer"},{"key":"1451_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/cancers15020504","volume":"15","author":"H Chhouri","year":"2023","unstructured":"Chhouri H, Alexandre D, Grumolato L. Mechanisms of acquired resistance and tolerance to EGFR targeted therapy in non-small cell lung cancer. Cancers. 2023;15:504.","journal-title":"Cancers"},{"key":"1451_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150517","volume":"132","author":"D Yan","year":"2022","unstructured":"Yan D, Huelse JM, Kireev D, Tan Z, Chen L, Goyal S, et al. MERTK activation drives osimertinib resistance in EGFR-mutant non\u2013small cell lung cancer. J Clin Invest. 2022;132:e150517.","journal-title":"J Clin Invest."},{"key":"1451_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21037\/tlcr.2016.12.02","volume":"5","author":"R Minari","year":"2016","unstructured":"Minari R, Bordi P, Tiseo M. Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance. Transl Lung Cancer Res. 2016;5:695\u201308.","journal-title":"Transl Lung Cancer Res"},{"key":"1451_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/1078-0432.CCR-19-3563","volume":"26","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ, Chan JM, Kubota D, Sato H, Rizvi H, Daneshbod Y, et al. Tumor analyses reveal squamous transformation and off-target alterations as early resistance mechanisms to first-line osimertinib in EGFR-mutant lung cancer. Clin Cancer Res. 2020;26:2654\u201363.","journal-title":"Clin Cancer Res"},{"key":"1451_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","volume":"14","author":"B Wang","year":"2019","unstructured":"Wang B, Wang M, Zhang W, Xiao T, Chen C-H, Wu A, et al. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nat Protoc. 2019;14:756\u201380.","journal-title":"Nat Protoc"},{"key":"1451_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.cellsig.2009.10.009","volume":"22","author":"AM Gonzalez","year":"2010","unstructured":"Gonzalez AM, Bhattacharya R, deHart GW, Jones JC. Transdominant regulation of integrin function: mechanisms of crosstalk. Cell Signal. 2010;22:578\u201383.","journal-title":"Cell Signal"},{"key":"1451_CR17","doi-asserted-by":"crossref","unstructured":"Samarzija I, Dekanic A, Humphries JD, Paradzik M, Stojanovic N, Humphries MJ, et al. Integrin crosstalk contributes to the complexity of signalling and unpredictable cancer cell fates. Cancers. 2020;12:1910.","DOI":"10.3390\/cancers12071910"},{"key":"1451_CR18","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1038\/onc.2013.391","volume":"33","author":"S Cagnet","year":"2014","unstructured":"Cagnet S, Faraldo MM, Kreft M, Sonnenberg A, Raymond K, Glukhova MA. Signaling events mediated by alpha3beta1 integrin are essential for mammary tumorigenesis. Oncogene. 2014;33:4286\u201395.","journal-title":"Oncogene"},{"key":"1451_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1172\/JCI42328","volume":"121","author":"NE Ramirez","year":"2011","unstructured":"Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O\u2019Rear LD, Nashabi A, et al. The alpha(2)beta integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest. 2011;121:226\u201337.","journal-title":"J Clin Invest"},{"key":"1451_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.matbio.2016.08.007","volume":"57-58","author":"V Ramovs","year":"2017","unstructured":"Ramovs V, Te Molder L, Sonnenberg A. The opposing roles of laminin-binding integrins in cancer. Matrix Biol. 2017;57-58:213\u201343.","journal-title":"Matrix Biol"},{"key":"1451_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18:533\u201348.","journal-title":"Nat Rev Cancer"},{"key":"1451_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.21037\/atm-20-5220","volume":"8","author":"J Wu","year":"2020","unstructured":"Wu J, Cheng J, Zhang F, Luo X, Zhang Z, Chen S. Estrogen receptor alpha is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer. Ann Transl Med. 2020;8:993.","journal-title":"Ann Transl Med"},{"key":"1451_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.14348\/molcells.2016.0210","volume":"39","author":"J Ryu","year":"2016","unstructured":"Ryu J, Koh Y, Park H, Kim DY, Kim DC, Byun JM, et al. Highly expressed integrin-alpha8 induces epithelial to mesenchymal transition-like features in multiple myeloma with early relapse. Mol Cells. 2016;39:898\u2013908.","journal-title":"Mol Cells"},{"key":"1451_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13277-015-3792-5","volume":"37","author":"X Lu","year":"2016","unstructured":"Lu X, Wan F, Zhang H, Shi G, Ye D. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Tumor Biol. 2016;37:253\u201362.","journal-title":"Tumor Biol"},{"key":"1451_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/or.2015.3993","volume":"34","author":"T Kok-Sin","year":"2015","unstructured":"Kok-Sin T, Mokhtar NM, Ali Hassan NZ, Sagap I, Mohamed Rose I, Harun R, et al. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data. Oncol Rep. 2015;34:22\u201332.","journal-title":"Oncol Rep"},{"key":"1451_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tcb.2016.02.001","volume":"26","author":"J Alanko","year":"2016","unstructured":"Alanko J, Ivaska J. Endosomes: emerging platforms for integrin-mediated FAK signalling. Trends Cell Biol. 2016;26:391\u20138.","journal-title":"Trends Cell Biol"},{"key":"1451_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","volume":"18","author":"SK Mitra","year":"2006","unstructured":"Mitra SK, Schlaepfer DD. Integrin-regulated FAK\u2013Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006;18:516\u201323.","journal-title":"Curr Opin Cell Biol"},{"key":"1451_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","volume":"165","author":"AK Sood","year":"2004","unstructured":"Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol. 2004;165:1087\u201395.","journal-title":"Am J Pathol"},{"key":"1451_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ceb.2005.08.007","volume":"17","author":"E Avizienyte","year":"2005","unstructured":"Avizienyte E, Frame MC. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol. 2005;17:542\u20137.","journal-title":"Curr Opin Cell Biol"},{"key":"1451_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1083\/jcb.200504124","volume":"171","author":"N Benlimame","year":"2005","unstructured":"Benlimame N, He Q, Jie S, Xiao D, Xu YJ, Loignon M, et al. FAK signaling is critical for ErbB-2\/ErbB-3 receptor cooperation for oncogenic transformation and invasion. J Cell Biol. 2005;171:505\u201316.","journal-title":"J Cell Biol"},{"key":"1451_CR31","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1038\/sj.onc.1209482","volume":"25","author":"SK Mitra","year":"2006","unstructured":"Mitra SK, Lim ST, Chi A, Schlaepfer DD. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene. 2006;25:4429\u201340.","journal-title":"Oncogene"},{"key":"1451_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.devcel.2005.06.006","volume":"9","author":"X Wu","year":"2005","unstructured":"Wu X, Gan B, Yoo Y, Guan JL. FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev Cell. 2005;9:185\u201396.","journal-title":"Dev Cell"},{"key":"1451_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/0008-5472.CAN-05-1149","volume":"66","author":"B Hu","year":"2006","unstructured":"Hu B, Jarzynka MJ, Guo P, Imanishi Y, Schlaepfer DD, Cheng SY. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res. 2006;66:775\u201383.","journal-title":"Cancer Res"},{"key":"1451_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1083\/jcb.200212114","volume":"160","author":"DA Hsia","year":"2003","unstructured":"Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol. 2003;160:753\u201367.","journal-title":"J Cell Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01451-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:27:44Z","timestamp":1745584064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01451-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1451"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01451-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}